Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

NCT03188874 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT03188874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2010
Completion date
September 30, 2030
Enrollment
15,000 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)